CABRINI, Giulio
 Distribuzione geografica
Continente #
NA - Nord America 942
EU - Europa 314
AS - Asia 302
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 1.561
Nazione #
US - Stati Uniti d'America 935
IT - Italia 142
CN - Cina 110
SG - Singapore 78
HK - Hong Kong 42
PL - Polonia 42
DE - Germania 35
ID - Indonesia 33
SE - Svezia 32
TR - Turchia 27
GB - Regno Unito 23
UA - Ucraina 21
CA - Canada 7
VN - Vietnam 7
FI - Finlandia 6
BE - Belgio 4
FR - Francia 3
IR - Iran 2
MK - Macedonia 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 1.561
Città #
Fairfield 126
Woodbridge 110
Ashburn 101
Chandler 73
Ferrara 73
Singapore 66
Houston 62
Wilmington 48
Cambridge 46
Seattle 43
Hong Kong 42
Warsaw 41
Jakarta 33
Ann Arbor 32
Jacksonville 30
Beijing 25
Shanghai 24
Izmir 19
Addison 18
Princeton 17
Los Angeles 15
Milan 11
Washington 11
Nanjing 10
Boardman 9
Bremen 8
Munich 8
Dong Ket 7
Santa Clara 7
Toronto 7
San Diego 6
Frankfurt am Main 5
Hebei 5
Mountain View 5
Bologna 4
Dearborn 4
Ferrara di Monte Baldo 4
Jiaxing 4
London 4
Nanchang 4
Padova 4
Brussels 3
Cesena 3
Changsha 3
Chicago 3
Harvard 3
Jinan 3
Norwalk 3
Redwood City 3
Trieste 3
Auburn Hills 2
Augusta 2
Bacoli 2
Brindisi 2
Chongqing 2
Des Moines 2
Groton 2
Guangzhou 2
Guarda Veneta 2
Naples 2
Paris 2
Pescara 2
Tappahannock 2
Tianjin 2
Albuquerque 1
Ardabil 1
Bevagna 1
Brno 1
Broomfield 1
Dalian 1
Dhaka 1
Dongyang 1
Falls Church 1
Fremont 1
Haikou 1
Helsinki 1
Hounslow 1
Jinhua 1
Kilburn 1
Leawood 1
Leuven 1
Lisbon 1
Monmouth Junction 1
North Charleston 1
North Chelmsford 1
Pacatuba 1
Parma 1
Perth 1
Redmond 1
Riyadh 1
Saint Louis 1
San Donà di Piave 1
Shenyang 1
Sindelfingen 1
Venice 1
Wuhan 1
Xi'an 1
Totale 1.259
Nome #
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 172
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 148
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 143
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 138
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 129
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 110
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 101
A new method for measuring local ATP release at the extracellular surface of live intact cells 86
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 58
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 56
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 53
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 51
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 50
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 42
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 39
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 38
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 36
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 34
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 32
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 29
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 28
Overview of CF lung pathophysiology 24
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 21
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 18
Totale 1.636
Categoria #
all - tutte 10.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020220 0 0 0 0 62 39 21 21 29 24 18 6
2020/2021272 13 5 9 16 12 22 40 29 20 40 34 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023191 21 34 4 19 22 14 25 10 16 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
2024/2025189 23 29 74 52 11 0 0 0 0 0 0 0
Totale 1.636